Cargando…
Stigmasterol prevents glucolipotoxicity induced defects in glucose-stimulated insulin secretion
Type 2 diabetes results from defects in both insulin sensitivity and insulin secretion. Elevated cholesterol content within pancreatic β-cells has been shown to reduce β-cell function and increase β-cell apoptosis. Hyperglycemia and dyslipidemia contribute to glucolipotoxicity that leads to type 2 d...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573401/ https://www.ncbi.nlm.nih.gov/pubmed/28842702 http://dx.doi.org/10.1038/s41598-017-10209-0 |